Zogenix, Inc. and Battelle to Present Positive, New Data Demonstrating Value of Needle-Free Injection for Biologics
5/20/2013 9:46:24 AM
More...
|
Zogenix, Inc. and Battelle Extend DosePro Co-Marketing Partnership
3/27/2013 10:52:52 AM
More...
|
Zogenix, Inc. Announces Conference Call and Webcast to Present Fourth Quarter and Full Year 2012 Financial Results
3/7/2013 11:40:55 AM
More...
|
FDA Delays Approval of Zogenix, Inc. Painkiller
2/27/2013 7:37:05 AM
More...
|
Zogenix, Inc. Announces Preliminary Fourth Quarter 2012 Gross Product Sales
1/7/2013 9:40:50 AM
More...
|
Zogenix, Inc. Reports Positive Results From Relday™ Phase 1 Clinical Trial
1/3/2013 8:57:01 AM
More...
|
FDA Panel Rejects Zogenix, Inc. Painkiller
12/10/2012 8:31:05 AM
More...
|
Zogenix, Inc. Drug May be Abused at Higher Rate, FDA Staff Says
12/5/2012 7:52:45 AM
More...
|
Zogenix, Inc. to Present at the 24th Annual Piper Jaffray Healthcare Conference
11/15/2012 7:31:45 AM
More...
|
Battelle and Zogenix, Inc. Release: Preliminary Findings From Rheumatoid Arthritis Patient Survey Reveal Strong Interest in Needle-Free Self-Injection
11/13/2012 8:32:30 AM
More...
|
|